The story of Viagra, originally marketed by copyright, presents a intricate case study for backers considering the pharmaceutical sector. While its groundbreaking success and generation of vast in revenue , the intellectual property end has opened the floodgates for generic medications, significantly diminishing income prospects . This change raise